Tyrosine kinase inhibitors (class)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tyrosine kinase inhibitors (class), covering 2017-06-07 to 2025-08-06. Get the full timeline:
Most recent: Clinical Trial Update: A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia